GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Yield10 Bioscience Inc (FRA:M6X) » Definitions » Cyclically Adjusted Revenue per Share

Yield10 Bioscience (FRA:M6X) Cyclically Adjusted Revenue per Share : €392.00 (As of Mar. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Yield10 Bioscience Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Yield10 Bioscience's adjusted revenue per share for the three months ended in Mar. 2024 was €0.532. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €392.00 for the trailing ten years ended in Mar. 2024.

During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was -53.80% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was -38.30% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was -18.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Yield10 Bioscience was -0.70% per year. The lowest was -53.80% per year. And the median was -6.15% per year.

As of today (2024-06-08), Yield10 Bioscience's current stock price is €4.4208. Yield10 Bioscience's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was €392.00. Yield10 Bioscience's Cyclically Adjusted PS Ratio of today is 0.01.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Yield10 Bioscience was 10.43. The lowest was 0.01. And the median was 0.22.


Yield10 Bioscience Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Yield10 Bioscience's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yield10 Bioscience Cyclically Adjusted Revenue per Share Chart

Yield10 Bioscience Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,391.17 4,654.87 5,107.52 1,029.04 454.77

Yield10 Bioscience Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 454.77 392.00

Competitive Comparison of Yield10 Bioscience's Cyclically Adjusted Revenue per Share

For the Agricultural Inputs subindustry, Yield10 Bioscience's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Yield10 Bioscience's Cyclically Adjusted PS Ratio Distribution in the Agriculture Industry

For the Agriculture industry and Basic Materials sector, Yield10 Bioscience's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Yield10 Bioscience's Cyclically Adjusted PS Ratio falls into.



Yield10 Bioscience Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Yield10 Bioscience's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.532/131.7762*131.7762
=0.532

Current CPI (Mar. 2024) = 131.7762.

Yield10 Bioscience Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 514.000 100.560 673.561
201409 490.000 100.428 642.953
201412 347.000 99.070 461.557
201503 298.000 99.621 394.187
201506 331.500 100.684 433.871
201509 97.000 100.392 127.324
201512 31.000 99.792 40.936
201603 47.000 100.470 61.645
201606 55.667 101.688 72.138
201609 140.333 101.861 181.547
201612 107.667 101.863 139.285
201703 101.000 102.862 129.391
201706 87.000 103.349 110.930
201709 46.750 104.136 59.159
201712 22.000 104.011 27.873
201803 4.900 105.290 6.133
201806 24.400 106.317 30.243
201809 6.500 106.507 8.042
201812 11.900 105.998 14.794
201903 10.000 107.251 12.287
201906 21.615 108.070 26.357
201909 15.615 108.329 18.995
201912 3.231 108.420 3.927
202003 2.282 108.902 2.761
202006 2.390 108.767 2.896
202009 1.663 109.815 1.996
202012 1.151 109.897 1.380
202103 0.922 111.754 1.087
202106 0.709 114.631 0.815
202109 0.384 115.734 0.437
202112 0.665 117.630 0.745
202203 0.662 121.301 0.719
202206 0.475 125.017 0.501
202209 0.000 125.227 0.000
202212 2.063 125.222 2.171
202303 0.000 127.348 0.000
202306 0.000 128.729 0.000
202309 0.000 129.860 0.000
202312 0.110 129.419 0.112
202403 0.532 131.776 0.532

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Yield10 Bioscience  (FRA:M6X) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Yield10 Bioscience's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=4.4208/392
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Yield10 Bioscience was 10.43. The lowest was 0.01. And the median was 0.22.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Yield10 Bioscience Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Yield10 Bioscience's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Yield10 Bioscience (FRA:M6X) Business Description

Industry
Traded in Other Exchanges
Address
19 Presidential Way, Woburn, MA, USA, 01801
Yield10 Bioscience Inc is an agricultural bioscience company. It focuses on developing disruptive technologies for step-change improvements in crop yield for food and feed crops to enhance global food security. The company uses two proprietary advanced biotechnology trait gene discovery platforms to improve fundamental crop yield through enhanced photosynthetic carbon capture and increased carbon utilization efficiency to increase seed yield. Having developed various crops, such as Camelina, canola, soybean, and corn, the firm concentrates to improve carbon dioxide fixation efficiency in photosynthesis and its direction to and conversion into plant matter.

Yield10 Bioscience (FRA:M6X) Headlines

No Headlines